Zacks Investment Research on MSN
ANGO stock dips despite Q2 earnings beat, gross margin improves
AngioDynamics, Inc. ANGO reported breakeven adjusted earnings per share for second-quarter fiscal 2026, marking an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback